1. PKU & GMP
  2. GMP Focus – 2021-2022 in review | Evidence Summary

GMP Focus – 2021-2022 in review | Evidence Summary

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

DESCRIPTION

With casein glycomacropeptide (GMP) continuing to be a focus point in IEM clinical research, we highlight select publications of interest over the last 10 months.

DOWNLOAD

Author

  • Vitaflo Dietitians

Published

  • 01/07/2022

TAGS

PKU & GMP
Rare Disorders of Protein Metabolism

OTHER RESOURCES YOU MAY BE INTERESTED IN

Webinars

Protein requirements & bioavailability in adults with PKU: Sharing latest research | Webinar recording

Practical Resources

Safety of Glycomacropeptide (GMP) in Phenylketonuria (PKU) | Evidence Summary
Practical Resources

Bone mass, density and geometry in phenylketonuria, reviewing the evidence | Evidence Summary
Practical Resources

PKU Bone Health | Evidence Summary

WE HAVE A WEALTH OF RESOURCES FOR

PKU - Infants

PKU - Children

PKU - Adolescents and Adults

Maternal PKU

PKU & GMP
Rare disorders

Rare Disorders of Protein Metabolism
Lipid disorder
Lipid disorder white

Lipid Disorders
GDS white

Glycogen Storage Disease
Ketogenic diet
Ketogenic diet white

Drug Resistant Epilepsy - Ketogenic Diet

Drug Resistant Epilepsy - K.Vita

Kidney Disease - Paediatric

Kidney Disease – Adults
Nutrican support
Nutrican support white

Nutrition Support